Thompson YY, Ramaswamy V, Diamandis P, Daniels C, Taylor MD. Posterior fossa ependymoma: current insights. Childs Nerv Syst. 2015;31(10):1699–706.
Article
PubMed
Google Scholar
Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8(4):323–35.
Article
CAS
PubMed
Google Scholar
Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011;20(2):143–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mack SC, Agnihotri S, Bertrand KC, Wang X, Shih DJ, Witt H, et al. Spinal myxopapillary ependymomas demonstrate a warburg phenotype. Clin Cancer Res. 2015;21(16):3750–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 2014;506(7489):445–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Raybaud C, Ramaswamy V, Taylor MD, Laughlin S. Posterior fossa tumors in children: developmental anatomy and diagnostic imaging. Childs Nerv Syst. 2015;31(10):1661–76.
Article
PubMed
Google Scholar
Mack SC, Witt H, Wang X, Milde T, Yao Y, Bertrand KC, et al. Emerging insights into the ependymoma epigenome. Brain Pathol. 2013;23(2):206–9.
Article
CAS
PubMed
Google Scholar
Bouffet E, Hawkins CE, Ballourah W, Taylor MD, Bartels UK, Schoenhoff N, et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys. 2012;83(5):1541–8.
Article
PubMed
Google Scholar
Dubuc AM, Mack S, Unterberger A, Northcott PA, Taylor MD. The epigenetics of brain tumors. Methods Mol Biol. 2012;863:139–53.
Article
CAS
PubMed
Google Scholar
Yao Y, Mack SC, Taylor MD. Molecular genetics of ependymoma. Chin J Cancer. 2011;30(10):669–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature. 2010;466(7306):632–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mack SC, Taylor MD. The genetic and epigenetic basis of ependymoma. Childs Nerv Syst. 2009;25(10):1195–201.
Article
PubMed
Google Scholar
Milde T, Hielscher T, Witt H, Kool M, Mack SC, Deubzer HE, et al. Nestin expression identifies ependymoma patients with poor outcome. Brain Pathol. 2012;22(6):848–60.
Article
PubMed
Google Scholar
Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009;10(3):258–66.
Article
PubMed
PubMed Central
Google Scholar
Bouffet E, Tabori U, Huang A, Bartels U. Ependymoma: lessons from the past, prospects for the future. Childs Nerv Syst. 2009;25(11):1383–4 (author reply 1385).
Article
PubMed
Google Scholar
Bouffet E, Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv Syst. 1999;15(10):563–70.
Article
CAS
PubMed
Google Scholar
Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T, et al. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed. 2011;10:7.
Article
PubMed
PubMed Central
Google Scholar
Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, et al. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. J Clin Oncol. 2016;34(21):2468–77.
Article
PubMed
Google Scholar
Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 2016;17(4):484–95.
Article
CAS
PubMed
Google Scholar